Management team
For its studies, Biophysium privileges the quality of scientific discussions with sponsors to fully understand your objectives in your projects. Thus, in order to provide robust data and innovative or up-to-date techniques with a high level of interpretation, our experts are at your disposal.
Biophysium’s management and scientific team includes doctors, engineers and technicians working with a network of privileged partners to offer an exceptional level of scientific expertise in our different models and in anticipation of clinical results. The whole team has a high level of experience in the field of drug discovery and preclinical development.
The reactivity of the customer relations team allows us to respond quickly to your questions before, during and after the studies.
Gaëtan Boléa, Ph.D
CEO, CSO, Founder, Chairman of the Scientific Advisory
Expert in cardiovascular physiology, echocardiography and nutraceutic.
Cyril Reboul, Ph.D, Full professor at Avignon University
Head of Pre-clinical studies department, member of the Scientific Advisory
Expert in echocardiography, cardiovascular physiology, mitochondria function.
Florence Coste, Pharm.D, Ph.D
Member of Scientific Advisory
Expert in pneumology and cardiovascular pharmacology, pathophysiology and cell biology.
Grégory Meyer, Ph.D
Head of ex-vivo studies and cell culture department, member of the Scientific Advisory
Expert in vascular function and nutraceutic.
Guillaume Walther, Ph.D
Head of Clinical studies department, member of the Scientific Advisory
Expert in vascular function, metabolic diseases and nutraceutic.
Maxime Gouin-Gravezat
PhD student
Achieved a master degree in vascular and metabolic diseases in 2023
Work on mitochondria function, calcium homeostasis and cardiovascular physiology.
